101 GLACIER POINT, SAN RAFAEL, CA
Board Resignation of Scott Davis Following Sale of Ekso Bionics, Inc.
Announces Agreements Bringing Total Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit
Annual Report to Security Holders
First Amendment to Secured Promissory Note with B. Riley Capital
Announces AI Infrastructure Partnership with Microsoft for 50 MW AI Compute Deployment in North America
CFO Appointment - Jerome Wong Continues as Chief Financial Officer
Amended material disclosure
ChronoScale Corporation Divests Ekso Bionics, Inc. Subsidiary
FY 2025
Q1
Amended Annual Report
FY 2024
Q3
Q2
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
PRER14A
PRE 14A
Definitive Information Statement
PRER14C
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Amended Schedule 13D - Ownership Report
S-8 POS